On Tuesday, Boston Scientific Corp (NYSE: BSX) was -0.35% drop from the session before settling in for the closing price of $96.43. A 52-week range for BSX has been $85.98 – $109.50.
A company in the Healthcare sector has dropped its sales by -17.84% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at 20.93%. With a float of $1.48 billion, this company’s outstanding shares have now reached $1.48 billion.
In an organization with 53000 employees, it is important to assess its efficiency.
Boston Scientific Corp (BSX) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Boston Scientific Corp stocks. The insider ownership of Boston Scientific Corp is 0.39%, while institutional ownership is 93.38%. The most recent insider transaction that took place on Dec 01 ’25, was worth 1,758,189. In this transaction EVP& Grp Pres, MedSurg & APAC of this company sold 17,313 shares at a rate of $101.55, taking the stock ownership to the 23,600 shares. Before that another transaction happened on Dec 01 ’25, when Company’s Officer proposed sale 17,313 for $101.55, making the entire transaction worth $1,758,188.
Boston Scientific Corp (BSX) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted 0.7 earnings per share (EPS) during the time that was better than consensus figure (set at 0.66) by 0.04. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.8 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 20.93% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 16.20% during the next five years compared to -17.84% drop over the previous five years of trading.
Boston Scientific Corp (NYSE: BSX) Trading Performance Indicators
You can see what Boston Scientific Corp (BSX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 0.96. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.36. Likewise, its price to free cash flow for the trailing twelve months is 37.25.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.87, a number that is poised to hit 0.78 in the next quarter and is forecasted to reach 3.47 in one year’s time.
Technical Analysis of Boston Scientific Corp (BSX)
Let’s dig in a bit further. During the last 5-days, its volume was 11.85 million. That was better than the volume of 8.25 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 82.09%.
During the past 100 days, Boston Scientific Corp’s (BSX) raw stochastic average was set at 29.72%, which indicates a significant decrease from 64.10% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 2.09 in the past 14 days, which was higher than the 2.04 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $98.58, while its 200-day Moving Average is $100.96. However, in the short run, Boston Scientific Corp’s stock first resistance to watch stands at $96.33. Second resistance stands at $96.57. The third major resistance level sits at $96.89. If the price goes on to break the first support level at $95.77, it is likely to go to the next support level at $95.45. The third support level lies at $95.21 if the price breaches the second support level.
Boston Scientific Corp (NYSE: BSX) Key Stats
There are 1,482,442K outstanding shares of the company, which has a market capitalization of 142.45 billion. As of now, sales total 16,747 M while income totals 1,854 M. Its latest quarter income was 5,065 M while its last quarter net income were 755,000 K.
